ABOCA & FEDEGARI: AN INCREASINGLY ECO-SUSTAINABLE PRODUCTION CYCLE
19 March 2020
WIND RIVER BATTLES COVID-19 ACCELERATING MISSION-CRITICAL INNOVATION
15 April 2020

HOME NEWS

BSM FILLS TREATMENT FOR COVID-19 IN FEDEGARI ISOLATOR

Berkshire Sterile Manufacturing is working on the production of new drugs to treat COVID-19

BSM has just finished the first fill and is now looking forward to rushing production of the experimental treatments to fight the coronavirus and help to save lives. Fedegari is proudly supporting the pharma industry on this challenging endeavor.

Using a Fedegari flexible isolator system to fill primary containers, Berkshire Sterile Manufacturing is tasked with manufacturing some of the first COVID-19 treatments to help those afflicted.

“We’ve been approached by three different companies. All three of which have been our clients and each of them have a COVID treatment,” said Andrea Wagner, BSM’s Senior VP Business Development.

 

“The COVID blocks the lungs from distributing oxygen to your body. These treatments are designed to open up your airways and get oxygen through”, completes Wagner.

Kinney explains, first of all,  that each of the three companies – who cannot be named due to confidentiality agreements – are approaching the problem from a different vantage point.

POSSIBLE VACCINE

 

Furthermore, BSM has also been approached by the US federal government asking the company to develop clinical material that could be used in a possible vaccine. Berkshire Sterile Manufacturing’s role in the process would be to sterilize material, then place it in vials and syringes so that to have it ready for clinical trials.

 

“Clinical trials are held on newly developed drugs to determine if they’re safe to put on the market”, Kinney explained.

 

 

BSM- FEDEGARI ISOLATOR

BSM semi-automated Fedegari filling line has a direct to enter

depyrogenation oven for bulk glassware and direct to enter lyophilizer.

1915 x 1277

Want to learn more about the project?

“The problem with many of these patients that get pneumonia is the inflammation of the lungs, and if they can disrupt the inflammation process so you don’t get inflammation these patients will be able to continue to breathe and hopefully do well,” explained Kinney.

 

COVID-19 TREATMENT DRUGS

 

One of the drug molecules attacks inflammation. A second drug might be able to boost the immune system of COVID-19 patients. Finally, the third drug seeks to expand how much oxygen the lungs can take in.

“If they can boost the immune system of people they are hoping that some of them won’t get to the advanced stages of pneumonia. Regarding the third drug, it might help people having difficulty to breathe. If they can improve the oxygen uptake, likewise it will offer greater support in the later stages of the disease,” Kinney said.

ABOUT BSM

Founded in 2014, Berkshire Sterile Manufacturing is located in Lee, Massachusetts. The company provides small scale sterile manufacturing services with the highest level of sterility assurance and quality achievable through the use of the most modern technologies for sterile manufacturing.

Learn more at berkshiresterilemanufacturing.com

SHAWN KINNEY, PH.D.
Chief Executive Officer
SHAWN KINNEY, PH.D. Chief Executive Officer

Discover our isolators and sterilizers

Flexible solutions to achieve the highest performances in sterile manufacturing.